| Taaffe et al. (20) 1999 California, United States | 53 healthy community-dwelling adults (65–79 years) (19 women; 34 men) IG1 (n = 14, 68.5 ± 3.6 years; 5 women, 9 men) IG2 (n = 14, 69.4 ± 3 years; 4 women, 10 men) IG3 (n = 11, 71 ± 4.1 years; 4 women, 10 men) CG (n = 14, 68.9 ± 3.6 years; 6 women, 8 men) Design: Randomized controlled trial. | Primary outcome Muscle strength: 1-RM Body Composition: Lean mass, fat mass (DXA) Secondary Outcome Physical Function: Balance (6-meter backward tandem walk) Muscle performance (Chair-rise test) | IG1: 24 weeks. High-intensity resistance training 1 day per week. (Minimum of 30-s rest between sets and at least 2 min between exercises) IG2: 24 weeks. High-intensity resistance training 2 days per week. (Minimum of 30-s rest between sets and at least 2 min between exercises) IG3: 24 weeks. High-intensity resistance training 3 days per week. (Minimum of 30-s rest between sets and at least 2 min between exercises) CG: Inactive | Measurements: At baseline After the intervention Dropout: IG1: 3 IG2: 2 IG3: 0 CG: 2 Adverse effects: Not mentioned. | Between-group comparisons: Muscle strength: Compared with CG: IG1, IG2, and IG3 showed significant improvements in muscle strength (p < 0.01). No differences were found between IG1, IG2 and IG3. Body composition: Compared with CG: IG1, IG2, and IG3 showed significant improvements in lean mass. No change in fat mass. Physical Function: Compared with CG: Chair-rise time decreased significantly in IG1, IG2, and IG3 (p < 0.01). The highest percentage of decreased was observed in IG3 (30.2 ± 11%). There were significant improvements in the time spent in 6-meter backward walk for the IG groups (p = 0.01) Within-group comparisons: Muscle strength: No significant differences were observed (p = 0.87) No other measures were reported. |
| Nemoto et al. (21) 2007 Matsumoto, Japan | 246 older adults (63 ± 6 years) (186 women; 60 men) IG1 (n = 84; men = 25, 67 ± 4 years; women = 59, 64 ± 6 years) IG2 (n = 75; men = 16, 67 ± 5 years; women = 59, 62 ± 5 years) CG (n = 87; men = 19, 66 ± 5 years; women = 68, 62 ± 6 years) Design: Randomized controlled trial. | Primary Outcome: Muscle strength: Knee extension and flexion forces (dynamometer) Body Composition: Body weight and BMI | IG1: High-intensity interval walking training. 5 sets (3 min low-intensity walking at 40% VO2 peak followed by 3-min high-intensity walking (>70% VO2 peak). Four or more days per week for 5 months. IG2: Moderate intensity continuous walking training: walk (50% VO2peak) 8,000 steps per day. 4 or more days per week for 5 months CG: No walking training | Measurements: At baseline At 5 months Dropout: IG1: 42 IG2: 24 CG: 41 Adverse effects: Not mentioned. | Between-group comparisons: Compared with CG, IG1 showed significant improvements in knee extension and flexion forces (p < 0.001) and in body weight (p < 0.001) and BMI (p < 0.004) in women. Compared with CG, IG2 showed a significant decrease in body weight and BMI (p < 0.001) in women. Compared with IG2, IG1 showed significant differences in knee flexion forces in men (p = 0.003), women (p = 0.02) and total number of participants (p = 0.004) Within-group comparisons: IG1 showed significant differences in isometric knee flexion (p < 0.001) and extension in women, men and total number of participants (p < 0.001), in BMI (p = 0.01) and body weight (p = 0.02) IG2 showed significant differences from pre-training values in isometric knee flexion in total number or participants (p < 0.001) in BMI (p < 0.001) and body weight (p < 0.001) |
| Villanueva et al. (22) 2014 California United States | 22 men (68 ± 4.1 years) IG (n = 11, 65.6 ± 3.4 years) CG (n = 11, 70.3 ± 4.9 years) Design: Randomized controlled trial. | Primary Outcome Body composition: (DEXA) Muscle strength: chest press and bilateral leg press exercises with (1-RM) Secondary Outcome Physical Function: Muscle performance (Margaria power test), balance (SEBT) and gait speed (400-m walk) | 12 weeks (4 weeks preparatory training + 8 weeks strength training). 36 Sessions (45–60 min), 3 days per week. IG: High intensity strength resistance training with short rest interval (60 s) CG: High intensity strength resistance training with extended rest interval (4 min) | Measurements: Prior to a 4-week control period. At baseline At 4 weeks At 8 weeks At 12 weeks Dropout: IG: 0 CG: 0 Adverse effects: No injuries, illness or personal choice were observed. | Between-group comparisons: Compared with CG, IG showed significant increases in lean body mass (p = 0.001), dynamic muscle strength (p < 0.001), and muscle performance (p < 0.001) Within-group comparisons: After intervention, IG showed significant improvements in lean body mass correlated with muscle strength: chest press (r = 0.88, p < 0.01), pulldown strength (r = 0.68, p < 0.05), and single-leg knee extension strength (r = 0.69, p < 0.05). |
| Sculthorpe et al. (23) 2017 Scotland United Kingdom | 33 sedentary men 56–65 years) IG (n = 22, 62.3 ± 4.1 years) CG (n = 11, 61.6 ± 5 years) Design: Randomized controlled trial. | Primary outcome: Muscle strength: Peak muscle power (Cycle ergometer) Body composition: TBM, FFM, FM (BIA) Secondary Outcome: Physical function: Static balance (Footscan portable foot pressure plate and stability) | IG: Conditioning exercise: 6 weeks. ≥5 days per week. Sessions of ≥ 30 min. HIIT intervention: 6 weeks. One session every 5 days. 5 min warm-up; 6 x 30 s sprints with 3-min intervals of active recovery. CG: Inactive | Measurements: At baseline At 6 weeks At 6 weeks Dropout: IG: 0 CG:0 Adverse effects: No adverse effects were reported. | Between-group comparisons: Compared with CG, IG showed significant differences in peak muscle power (p < 0.01) and lean body mass (p < 0.01). Regarding static balance, no significant differences were observed. Within-group comparisons: After the intervention, IG showed significant improvements in peak muscle power (p < 0.01), lean body mass (p < 0.05), and a significant decrease in total body fat (p < 0.05) |
| Moro et al. (24) 2017 Padua Italy | 35 older adults (15 women; 20 men) IG1 (n = 18, 64.1 ± 2.3 years; women = 8; men = 10) CG (n = 17, 61.7 ± 4.2 years; women = 7; men = 10) Design: Randomized controlled clinical trial. | Primary Outcome: Body composition: Height and body weight (digital electronic scale), FFM and FM (BIA) Muscle strength: 3–6 RM strength (leg extension, chest press, lat pull down and arm curl) | IG1: 2 months. 2 times per week (45 min). HIIRT (high intensity interval resistance training): 2 series of 6RM at 80% 1RM followed by 20 ″of rest, repetitions to failure, another 20″ of rest, and repetitions to failure. CG: 2 months. 2 times per week TRT (traditional resistance training): 3 series of 8 repetitions at 75% 1RM. | Measurements: At baseline After the intervention Dropout: IG1: 4 CG:8 Adverse effects: Not mentioned. | Between-group comparisons: Strength increased in IG1 and in CG (p < 0.001), without significant difference between them. Within-group comparisons: IG1 and CG showed a small Cohen's effect size for body weight: CG (0.01) IG1 (0.02), FFM: CG (0.26) IG1 (0.15), and FM: CG (0.07) and IG (0.11). |
| García-Pinillos et al. (16) 2017 Jaén, Spain | 90 older adults (72 ± 5 years) (64 women; 26 men) IG1 [n = 47, 73.50 ± 5.58 years; women = 34 (72.3%), men = 13 (27.7%)] CG [n = 43, 72.09 ± 5.78 years; women= 30 (69.8%), men = 13 (30.2%)] Design: Randomized controlled clinical trial. | Primary Outcome: Body composition: BMI, body mass, fat mass, SMM (eight-polar tactile electrode BIA) Muscle strength: Lower-body muscle strength (30-s CST) and upper-body muscle strength Hand-grip strength (hand dynamometer) Secondary Outcome Physical function: Gait speed (GS) and Balance (FreeMed© BASE model baropodometric platform) | IG1: 12 weeks; 3 times per week (35–40 min). HIIT: High-intensity strength training combined with high-intensity interval endurance training Warm-up (5–7 min) High-intensity strength training + high-intensity interval endurance training + High-intensity strength training and cool down (4–5 min) CG: Walking (150–200 min per week at low-moderate intensity) | Measurements: At baseline At 12 weeks Dropout: IG1: 0 CG:4 Adverse effects: No adverse events were reported. | Between-group comparisons: Compared with CG, IG1 showed significant improvements in BMI, fat mass, and SMM (p < 0.005). Also showed significant differences in 30-s CST (p < 0.001) and hand-grip strength (p = 0.048), GS (p = 0.007), and length balance (p = 0.003). Within-group comparisons: IG1 showed significant interactions in body mass, fat mass, muscle mass, BMI, 30-s CST, hand-grip strength, GS (p < 0.001), and balance for ellipse area (p = 0.031) and length (p < 0.001) CG: No significant differences were observed (p ≥ 0.05) |
| Jiménez-García et al. (25) 2019 Málaga, Spain | 82 older adults (68.23 ± 2.97 years) (women 75.61%) IG1 (n = 28, 68.23 ± 2.97 years; women 92.3%) IG2 (n = 27, 68.75 ± 5.98 years, women 70.8%) CG (n = 27, 68.52 ± 6.33 years; women 65.2%) Design: Randomized controlled clinical trial. | Primary Outcome: Muscle strength: Hand-grip strength (hand-grip dynamometer) Body composition: SMM and PBF (BIA) Secondary Outcome Physical Function: Gait speed (TUG) | IG1: High-intensity interval exercise (HIIT). 12 weeks; 2 times per week. Warm-up (10 min); 4 sets of squat activity with suspension 90–95% max HR followed by active rest intervals (90–95% max HR) followed by 3-min active rest intervals (50–70%) and a cool-down (10 min). IG2: Continuous-intensity-training (MIIT). 12 weeks; 2 times per week. Warm-up (10 min); 4 sets of squat activity with suspension 70–50% max HR followed by active rest intervals (70–50% max HR) followed by 3-min active rest intervals (50–70%) and a cool-down (10 min). CG: their daily lifestyle and a guideline to encourage physical activity | Measurements: At baseline At 12 weeks Dropout: IG1: 2 IG2:3 CG:4 Adverse effects: Injuries and other effects were observed. | Between-group comparisons: Compared with CG, IG1 showed significant differences in BMI (p < 0.001) and gait speed (p < 0.001). Compared with IG2, IG1 showed significant improvements in BMI (p = 0.002) and gait speed (p < 0.001). Compared with CG, IG2 showed significant differences in BMI (p = 0.01). No significant differences were observed for SMM, PBF, or hand-grip strength. Within-group comparisons: IG1 showed significant improvements in hand-grip strength (p = 0.002), gait speed (p = 0.002) |
| Ballesta-García et al. (26) 2019 Murcia, Spain | 54 women (67.8 ± 6.2 years) IG1 (n = 18, 66.3 ± 5.44 years) IG2 (n = 18, 70 ± 8.76 years) CG (n = 18, 67.4 ± 5.71 years) Design: Randomized controlled trial. | Primary Outcome: Body composition: BMI (electronic balance and a height rod) Muscle strength: Hand-grip strength (dynamometer); Upper-limb strength (ACT-30) and lower-limb strength (STS-30) Secondary Outcome: Physical function: Gait speed (TUG) and balance (OLS) | IG1: 18 weeks; 2 times per week (1 h). High-intensity interval training in a circuit program: (Warm-up, HIIT (14–18 point of RPE) and cool-down) IG2: 18 weeks; 2 times per week (1h). Moderate-intensity continuous training: (Warm-up, (9–14 point of RPE) and cool-down) CG: Their physical activity habits. | Measurements: At baseline At 18 weeks Dropout: IG1: 1 IG2:6 CG:6 Adverse effects: 5 subjects presented adverse effects during the study. | Between-group comparisons: Compared with CG, IG1 showed significant improvements in ACT-30 (p < 0.001), STS-30 (p < 0.001), TUG (p < 0.001) and BMI (p < 0.001). Compared with CG, IG2 showed significant improvements STS-30 (p < 0.001) and TUG (p < 0.001). Compared with IG2, IG1 showed significant improvements in 30-second ACT (p < 0.001). Within-group comparisons: IG1 showed significant improvements in STS-30 (p < 0.001), TUG (p < 0.001), ACT-30 (p = 0.022), right OLS (p = 0.024), and BMI (p = 0.035). IG2 showed significant improvements (p < 0.001) in STS-30 and TUG. CG showed significant improvements in ACT-30 (p < 0.001), STS-30 (p < 0.001), TUG (p = 0.016), and BMI (p = 0.019). |